What changed in this filing

/stocks — the workspaceLOADING

Item 5. Other Information

2025-08-05 compared with 2025-05-06 · 36 added, 35 removed, 8 unchanged (90% of the section changed)

OTHER INFORMATION

On March 13, 2025 , Marc Benathen ,

Chief Financial Officer , adopted a Rule 10b5-1 trading arrangement that is intended to satisfy the affirmative defense of Rule 10b5-1(c)

for the sale of up to 200,000 shares of the Company’s common stock, at various limit prices above the current market price of the

Company’s common stock as of the plan adoption date, with such transactions to occur during sale periods beginning on or after June

13, 2025 and ending on the earlier of May 31, 2026 or the date on which all shares authorized for sale have been sold in conformance with

the terms of the arrangement.

March 13, 2025 , Nicholas Alvarez , Chief Acquisition Officer , adopted a Rule 10b5-1 trading arrangement that is intended to satisfy the

affirmative defense of Rule 10b5-1(c) for the sale of up to 300,000 shares of the Company’s common stock, at various limit prices

above the current market price of the Company’s common stock as of the plan adoption date, with such transactions to occur during

sale periods beginning on or after July 1, 2025 and ending on the earlier of April 10, 2026 or the date on which all shares authorized

for sale have been sold in conformance with the terms of the arrangement.

Incorporated by Reference

Exhibit Number

Exhibit Description

Filing Date/Period End Date

12, 2025 , Nicholas

Alvarez , Chief

Acquisition Officer , terminated

a Rule 10b5-1 trading arrangement adopted

on March 13, 2025 , that was intended to satisfy the affirmative defense of Rule 10b5-1(c) for the sale of up to 300,000 shares

of the Company’s common stock, at various limit prices above the current market price of the Company’s common stock as

of the plan adoption date, with such transactions to have occurred during sale periods beginning on or after July 1, 2025 and ending

on the earlier of April 10, 2026 or the date on which all shares authorized for sale would have been sold in conformance with the

terms of the arrangement.

Date/Period End Date

Confidential Offer Letter, dated April 14, 2021 between LifeMD, Inc.

and Shayna Webb Dray

First Amendment to Employment Agreement, dated November 8, 2023 between LifeMD, Inc.

and Shayna Webb Dray

Second Amendment to Employment Agreement, dated May 7, 2024 between LifeMD, Inc.

and Shayna Webb Dray

Third Amendment to Employment Agreement, dated July 27, 2025 between LifeMD, Inc.

and Shayna Webb Dray

Restricted Stock Unit Award Agreement, dated July 27, 2025, between LifeMD, Inc.

and Shayna Webb Dray

Rule 13a-14(a) / 15d-14(a) Certification of Chief Executive Officer.

2 unchanged sentences

Section 1350 Certification of Chief Financial Officer.

Inline XBRL Instance Document

Inline XBRL Taxonomy Extension Schema Document

Inline XBRL Taxonomy Extension Calculation Linkbase Document

Inline XBRL Taxonomy Extension Definition Linkbase Document

Inline XBRL Taxonomy Extension Label Linkbase Document

Inline XBRL Taxonomy Extension Presentation Linkbase Document

Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101.INS)

XBRL Instance Document

XBRL Taxonomy Extension Schema Document

XBRL Taxonomy Extension Calculation Linkbase Document

XBRL Taxonomy Extension Definition Linkbase Document

XBRL Taxonomy Extension Label Linkbase Document

XBRL Taxonomy Extension Presentation Linkbase Document

Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101.INS)

Indicates management contract or compensatory plan, contract or arrangement.

Filed herewith.

**Furnished herewith

Pursuant to the requirements of

Section 13 or 15(d) of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the

undersigned, thereunto duly authorized.

/s/ Justin Schreiber

to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed

on its behalf by the undersigned, thereunto duly authorized.

Justin Schreiber

Chief Executive Officer and Chairman of the Board of Directors

(principal executive officer)

/s/ Marc Benathen

Executive Officer and Chairman of the Board of Directors

executive officer)

Marc Benathen

Chief Financial Officer

(principal financial officer)

/s/ Maria Stan

Chief Accounting Officer and Controller

(principal accounting officer)

Financial Officer

financial officer)

Accounting Officer and Controller

accounting officer)

Compared sentence by sentence after normalising whitespace, quotation marks, case and digits, so re-formatting and restated figures do not read as changed language. Wording changes appear as one removal and one addition. The current filing and the prior one are authoritative.

What changed 10-Q

Item 5. Other Information